Vanna Hovanky

Statistics

Publications

Citations

296

H-Index

Active since

2022

Affiliations

Stanford University(Current)

Moffitt Cancer Center

The University of Texas MD Anderson Cancer Center

Cleveland Clinic

Levine Cancer Institute

Vanna Hovanky is an author at Stanford University specializing in relapsed multiple myeloma, multiple myeloma therapy, and refractory multiple myeloma.

Publications per year

2022–2025

Publications

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 124 citations · Full text

Medicine, Hematology, Oncology +14

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi et al. · Blood Advances · 2022 · 99 citations · Full text

Medicine, Hematology, Oncology +14

Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment

Surbhi Sidana, Lauren C. Peres, Hamza Hashmi et al. · Haematologica · 2023 · 41 citations · Full text

Medicine, Immunology, Nephrology +15

Clinical outcomes after idecabtagene vicleucel in older patients with multiple myeloma: a multicenter real-world experience

Nilesh Kalariya, Michelle A.T. Hildebrandt, Doris K. Hansen et al. · Blood Advances · 2024 · 17 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma

Hitomi Hosoya, Mia Carleton, Kailee Tanaka et al. · Nature Communications · 2025 · 15 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 5